Daily SPAC Update – August 4, 2025

by | Aug 4, 2025

CSLM + Fusemachines Deal Approved (plus FPA). Helix Aquisition II + Bridge Bio Oncology Therapeutics Deal Vote. Blue Acquisition Separate Trading.

Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

SPAC VOTE RESULTS
CSLMF – CSLM ACQUISITION CORP * Deal Approved with Fusemachines Inc.

MERGER VOTES
HLXB – Helix Acquisition Corp II + BridgeBio Oncology Therapeutics
BridgeBio Oncology Therapeutics (BBOT) is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Kα malignancies. Initially formed as a subsidiary of BridgeBio Pharma, Inc. (Nasdaq: BBIO), BBOT has the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors. For more information, visit bridgebiooncology.com.

OTHER SPAC NEWS
CSLMF – CSLM ACQUISITION CORP * Forward Purchase Agreement
PLMJF – PLUM ACQUISITION CORP III * Merger Agreement Amendment
CCCM – COLUMBUS CIRCLE CAPITAL CORP I * Media Transcript

SEPARATE WARRANTS/RIGHTS
Aug 04: BLUE ACQUISITION CORP (BACC)

SPAC DEALS ANNOUNCED
Jul 31 | MACI – Melar Acquisition Corp I + Everli Global Inc.

ABOUT Everli Global Inc.
Everli is a major e-grocery technology & fulfillment platform in Italy, seamlessly connecting consumers with their favorite grocery retailers through a fully integrated digital marketplace. By managing the entire logistics chain, from online ordering to in-store picking and last-mile delivery, Everli empowers retailers to offer a premium online shopping experience without the need for additional infrastructure, staffing, or operational changes. Its model is built on exclusive partnerships with the country’s top grocery chains, ensuring broad product availability and trusted brand access for consumers. At the heart of Everli’s operations is a dedicated network of trained shoppers who ensure accuracy, freshness, and reliability with every order. Everli’s union-endorsed delivery framework reinforces its commitment to fair labor practices while supporting consistent service quality at scale.

Jul 31 | SVII – Spring Valley Acquisition Corp Ii + Eagle Energy Metals Corp.

ABOUT Eagle Energy Metals Corp.
Eagle Energy Metals Corp. is a next-generation nuclear energy company that combines domestic uranium exploration with proprietary Small Modular Reactor (SMR) technology. The Company holds the rights to the largest mineable, measured and indicated uranium deposit in the United States, located in southeastern Oregon. This includes the Aurora deposit, with over 50 million pounds4 of near-surface uranium resource, and the adjacent Cordex deposit, which offers significant potential to expand the project’s overall resource inventory. By integrating advanced SMR technology with a sizeable uranium asset, Eagle is building an integrated nuclear platform positioned to help restore American leadership in the global nuclear industry.

NEW SPAC IPOs
Aug 01: HCMA – Hcm Iii Acquisition Corp. $220M IPO
Jul 30: APAD – A Paradise Acquisition Corp. $200M IPO

SPAC Movers

YESTERDAY’S TOP SPAC GAINERS
1.21% ~ $ 12.55 | ISRL – ISRAEL ACQUISITIONS CORP (Announced)
.57% ~ $ 10.65 | EURK – EUREKA ACQUISITION CORP (Pre-Deal)
.30% ~ $ 10.10 | CHAC – CRANE HARBOR ACQUISITION CORP (Pre-Deal)
.29% ~ $ 10.22 | IPCX – INFLECTION POINT ACQUISITION CORP III (Pre-Deal)
.20% ~ $ 10.09 | COPL – COPLEY ACQUISITION CORP (Pre-Deal)

YESTERDAY’S TOP SPAC LOSERS
-22.05% ~ $ 10.29 | FACT – FACT II ACQUISITION CORP (Pre-Deal)
-8.75% ~ $ 26.50 | CEP – CANTOR EQUITY PARTNERS INC (Announced)
-5.42% ~ $ 10.12 | CHEB – CHENGHE ACQUISITION II CO (Announced)
-3.81% ~ $ 10.87 | DYCQ – DT CLOUD ACQUISITION CORP (Announced)
-2.56% ~ $ 10.64 | IROH – IRON HORSE ACQUISITIONS CORP (Announced)

LATEST SPAC IPO PERFORMANCE
Aug 01 | HCMA – HCM III Acquisition Corp.
Jul 30 | APAD – A Paradise Acquisition Corp.
Jul 17 | $ 10.03 | PAII – Pyrophyte Acquisition Corp. II
Jul 16 | $ 10.06 | SOCA – Solarius Capital Acquisition Corp.
Jul 15 | $ 10.13 | SPEG – Silver Pegasus Acquisition Corp.
Jul 09 | $ 10.17 | GTER – Globa Terra Acquisition Corporation

 

Recent Analysis

Executive Moves Update – August 1, 2025

CEO and CFO transitions at Dexcom, Carlyle, Roku, Warner Bros. Discovery, MetLife, and Five9. New board members at Chevron, BioMarin, Celestica, Elevance Health, GXO Logistics, and more. Executive leadership changes and governance red flags across U.S. public companies for the week of July 28 – August 1, 2025.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.